COVID-19 vaccine reaches phase-2 trials in China
BEIJING, June 20 (Xinhua) -- An inactivated COVID-19 vaccine candidate developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences has entered phase-2 clinical trials in China, the Science and Technology Daily reported Saturday.
The phase-2 trials, which further evaluate the immunogenicity and safety of the vaccine in humans, are conducted in the southwestern province of Yunnan.
- Read more about COVID-19 vaccine reaches phase-2 trials in China
- Log in or register to post comments